JP2012532179A5 - - Google Patents

Download PDF

Info

Publication number
JP2012532179A5
JP2012532179A5 JP2012518920A JP2012518920A JP2012532179A5 JP 2012532179 A5 JP2012532179 A5 JP 2012532179A5 JP 2012518920 A JP2012518920 A JP 2012518920A JP 2012518920 A JP2012518920 A JP 2012518920A JP 2012532179 A5 JP2012532179 A5 JP 2012532179A5
Authority
JP
Japan
Prior art keywords
arg
asp
pro
glu
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012518920A
Other languages
English (en)
Japanese (ja)
Other versions
JP5675799B2 (ja
JP2012532179A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/059438 external-priority patent/WO2011003823A1/de
Publication of JP2012532179A publication Critical patent/JP2012532179A/ja
Publication of JP2012532179A5 publication Critical patent/JP2012532179A5/ja
Application granted granted Critical
Publication of JP5675799B2 publication Critical patent/JP5675799B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012518920A 2009-07-06 2010-07-02 遅効性インスリン製剤 Expired - Fee Related JP5675799B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE102009031750.3 2009-07-06
DE102009031750 2009-07-06
US26435309P 2009-11-25 2009-11-25
US61/264,353 2009-11-25
DE102010013133.4 2010-03-27
DE102010013133 2010-03-27
PCT/EP2010/059438 WO2011003823A1 (de) 2009-07-06 2010-07-02 Langsamwirkende insulinzubereitungen

Publications (3)

Publication Number Publication Date
JP2012532179A JP2012532179A (ja) 2012-12-13
JP2012532179A5 true JP2012532179A5 (https=) 2013-08-08
JP5675799B2 JP5675799B2 (ja) 2015-02-25

Family

ID=43428815

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012518920A Expired - Fee Related JP5675799B2 (ja) 2009-07-06 2010-07-02 遅効性インスリン製剤

Country Status (7)

Country Link
US (1) US20120232002A1 (https=)
EP (1) EP2451471A1 (https=)
JP (1) JP5675799B2 (https=)
AR (1) AR077455A1 (https=)
TW (1) TW201113032A (https=)
UY (1) UY32765A (https=)
WO (1) WO2011003823A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102007143B (zh) 2008-01-09 2015-08-26 塞诺菲-安万特德国有限公司 具有超延迟时效特征的新型胰岛素衍生物
CN102256618A (zh) 2008-10-17 2011-11-23 赛诺菲-安万特德国有限公司 胰岛素和glp-1激动剂的组合
PL2451437T3 (pl) * 2009-07-06 2017-05-31 Sanofi-Aventis Deutschland Gmbh Wodne preparaty insuliny zawierające metioninę
NZ599847A (en) 2009-11-13 2013-09-27 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
WO2012028172A1 (en) 2010-08-30 2012-03-08 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
TWI780236B (zh) 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
US9895423B2 (en) 2014-01-09 2018-02-20 Sanofi Stabilized pharmaceutical formulations of insulin aspart
CN105960249B (zh) 2014-01-09 2021-03-16 赛诺菲 胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂
JP6723921B2 (ja) 2014-01-09 2020-07-15 サノフイＳａｎｏｆｉ インスリンアナログおよび／またはインスリン誘導体の、グリセリンを含まない安定化された医薬製剤
WO2016001862A1 (en) 2014-07-04 2016-01-07 Wockhardt Limited Extended release formulations of insulins
PE20171622A1 (es) 2014-12-12 2017-11-02 Sanofi Aventis Deutschland Formulacion de relacion fija de insulina glargina/lixisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3316363A1 (de) 1983-05-05 1984-11-08 Deutsche Babcock Anlagen Ag, 4200 Oberhausen Walzenrost fuer muellverbrennungsanlagen
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK257988D0 (da) * 1988-05-11 1988-05-11 Novo Industri As Nye peptider
DE3837825A1 (de) * 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US5225323A (en) * 1988-11-21 1993-07-06 Baylor College Of Medicine Human high-affinity neurotransmitter uptake system
KR910700262A (ko) 1988-12-23 1991-03-14 안네 제케르 사람 인슐린 유사체
PT93057B (pt) 1989-02-09 1995-12-29 Lilly Co Eli Processo para a preparacao de analogos da insulina
DK155690D0 (da) 1990-06-28 1990-06-28 Novo Nordisk As Nye peptider
EA200000453A1 (ru) * 1997-10-24 2000-10-30 Эли Лилли Энд Компани Композиции нерастворимого инсулина
US6444641B1 (en) * 1997-10-24 2002-09-03 Eli Lilly Company Fatty acid-acylated insulin analogs
EP1076066A1 (en) * 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
AU2002248464A1 (en) * 2001-02-21 2002-09-12 Medtronic Minimed, Inc. Stabilized insulin formulations
AU2003268621B2 (en) * 2002-10-02 2009-01-15 Zealand Pharma A/S Stabilized exendin-4 compounds
WO2007081824A2 (en) * 2006-01-06 2007-07-19 Case Western Reserve University Fibrillation resistant proteins
DE102006031962A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
DK2074141T3 (en) * 2006-09-22 2016-11-28 Novo Nordisk As The protease resistant insulin analogues.
CN102007143B (zh) * 2008-01-09 2015-08-26 塞诺菲-安万特德国有限公司 具有超延迟时效特征的新型胰岛素衍生物
WO2011003820A1 (de) * 2009-07-06 2011-01-13 Sanofi-Aventis Deutschland Gmbh Hitze- und schüttelstabile insulinzubereitungen
PL2451437T3 (pl) * 2009-07-06 2017-05-31 Sanofi-Aventis Deutschland Gmbh Wodne preparaty insuliny zawierające metioninę
TR201809460T4 (tr) * 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.

Similar Documents

Publication Publication Date Title
JP2012532179A5 (https=)
JP7461997B2 (ja) 制御放出および持続的放出のためのｅｌｐ融合タンパク質
CA3011480C (en) Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
JP5694779B2 (ja) 極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体
JP2011509269A5 (https=)
TWI547499B (zh) 胰高血糖素/glp-1受體協同激動劑
JP5780958B2 (ja) ハロゲン安定化インスリン
US20090215688A1 (en) GLP-I Agonist And Cardiovascular Complications
CN103596583B (zh) 新型胰高血糖素类似物
RU2010133233A (ru) Новые производные инсулина с сильно замедленным профилем время/действие
TW201127395A (en) Pharmaceutical composition comprising a GLP-1 agonist and methionine
US9388228B2 (en) Halogen-stabilized insulin
RU2012103901A (ru) Препарат инсулина, содержащий метионин
US20150299286A1 (en) Glutamic acid-stabilized insulin analogues
US20120277148A1 (en) Insulin analogues with chlorinated amino acids
WO2014081849A1 (en) Formulations of active agents for sustained release
US9200053B2 (en) Insulin analogues containing penta-fluoro-Phenylalanine at position B24
WO2023143458A1 (zh) 酰化胰岛素
AU2013237740B2 (en) Insulin analogues containing penta-fluora-phenyalanine at position B24